ACTU vs PARA · $49.0M cap vs rev $5.0M
Actuate Therapeutics, Inc. Common stock (ACTU) versus PARA (PARA) — a side-by-side from cached financials, not a winner call.
Actuate Therapeutics, Inc. Common stock (ACTU) is a biotechnology company listed on NASDAQ.
PARA (PARA) common stock.
ACTU does not have a complete income-statement cache yet.
Latest reported PARA revenue for 2026-06-30 was $5.0M. Net income was -$13.4M. Revenue was up 84.3% from 2026-03-31 to 2026-06-30. PARA currently screens at market cap $0.
ACTU currently screens at market cap $49.0M. PARA currently screens at market cap $0.
Not investment advice. Open the ACTU and PARA stock pages for the full models.
Not investment advice.